Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Machine Learning in Drug Development for Neurological Diseases: A Review of Blood Brain Barrier Permeability
Aryon Eckleel Nabi1, Pedram Pouladvand2, Litian Liu3
1Harvard Medical School, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Abstract:
The blood brain barrier (BBB) is an endothelial-derived structure which restricts the movement of certain molecules between the general somatic circulatory system to the central nervous system (CNS). While the BBB maintains homeostasis by regulating the molecular environment induced by cerebrovascular perfusion, it also presents significant challenges in developing therapeutics intended to act on CNS targets. Many drug development practices rely partly on extensive cell and animal models to predict, to an extent, whether prospective therapeutic molecules can cross the BBB. In interest to reduce costs and improve prediction accuracy, many propose using advanced computational modeling of BBB permeability profiles leveraging empirical data. Given the scale of growth in machine learning and deep learning, we review the most recent machine learning approaches in predicting BBB permeability.
Related Concept Videos
The Blood-brain Barrier
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

